InsiderDB
Sign inStart free trial

Moderna (MRNA)

Healthcare · Biotechnology

6 members of Congress have disclosed 18 trades in Moderna (MRNA) since 2023: 7 buys and 11 sales. The most recent was disclosed on Nov 5, 2026.

Trades disclosed
18
Members trading
6
Buys / sells
7 / 11
Reported value
$165K–$525K

Keep following the company.

Subscribers get new congressional filings and notable insider purchases for companies they follow. Coverage varies by company.

Follow MRNA

Research connections

Patterns in the available disclosures. Each source has its own timing and reporting limits.

2 congressional households disclosed buys

Disclosures in the past 90 days. These may cover different transaction dates and owners.

What else is happening at MRNA

All research →

Company filings and public records connected to this stock, ordered by when they became public or were first observed.

  1. MRNAFinancial report·SEC EDGAR

    MRNA: 10-Q financial filing

    Filed 10-Q for an event or period dated 2026-09-30. Read the company report for its disclosures.

    Public: Nov 6, 2026, 4:06 PM ESTEvent / period: Sep 30, 2026Original source ↗

    2 congressional households disclosed purchases in the past 90 days. See the trades

  2. MRNACompany announcement·SEC EDGAR

    MRNA: Financial results

    Filed 8-K for an event or period dated 2026-11-06. Financial results.

    Public: Nov 6, 2026, 6:47 AM ESTEvent / period: Nov 6, 2026Original source ↗

    2 congressional households disclosed purchases in the past 90 days. See the trades

  3. MRNALobbying report·Lobbying disclosures

    MRNA: third_quarter 2026 lobbying report

    Issues related to the Vaccine Injury Compensation Program (VICP); Issues related to vaccine safety and approval; Issues related to FDA's approval of Moderna's flu vaccine; Issues related to Messenger RNA (mRNA) therapies

    Public: Oct 20, 2026, 4:00 PM EDTOriginal source ↗

    2 congressional households disclosed purchases in the past 90 days. See the trades

  4. MRNALobbying report·Lobbying disclosures

    MRNA: third_quarter 2026 lobbying report

    Vaccine Policy, FDA Vaccine Approval, mRNA Federal Policy, Oncology Innovation, Vaccines for Children Program, Patent Litigation

    Public: Oct 16, 2026, 4:27 PM EDTOriginal source ↗

    2 congressional households disclosed purchases in the past 90 days. See the trades

  5. MRNALobbying report·Lobbying disclosures

    MRNA: third_quarter 2026 lobbying report

    Tax Reform - Restoring the Orphan Drug Tax Credit.

    Public: Oct 7, 2026, 1:13 PM EDTOriginal source ↗

    2 congressional households disclosed purchases in the past 90 days. See the trades

Who traded MRNA

All trades

1 new trade of MRNA in the last 24 hours. Members got it by email.

Sign inStart free trial →

From periodic transaction reports filed under the STOCK Act. Amounts are the ranges members report, and trades can be disclosed up to 45 days after they happen. Nothing here is investment advice.